S phingosine-1-phosphate (S1P) is a bioactive lipid mediator with crucial roles in a wide variety of cellular functions across a broad range of organisms. Though a simple molecule in structure, S1P functions are complex. The formation of S1P is catalyzed by one of two sphingosine kinases that have differential cellular distributions as well as both overlapping and opposing functions and which are activated by many different stimuli. S1P can act on a family of G protein-coupled receptors (S1PRs) that are also differentially expressed in different cell types, which influences the cellular responses to S1P. In addition to acting on receptors located on the plasma membrane, S1P can also function inside the cell, independently of S1PRs. It also appears that both the intracellular location and the isotype of sphingosine kinase involved are major determinants of inside-out signaling of S1P in response to many extracellular stimuli. This chapter is focused on the current literature on extracellular and intracellular actions of S1P.
Introduction
In just over a decade, the sphingolipid metabolite, sphingosine-1-phosphate (S1P), has emerged as a key regulator of numerous physiological functions, including cell growth and survival, angiogenesis, cell motility and migration and lymphocyte trafficking. 1 S1P promotes cell growth and inhibits apoptosis, while its precursors, ceramide and sphingosine, typically inhibit cell growth and induce apoptosis. 1 Therefore, the cellular balance of these three sphingolipid metabolites, the "sphingolipid rheostat", is of crucial importance in regulating cell fate. 1 Moreover, sphingolipid metabolism has been found to be dysregulated in many human diseases, including cancer, inflammation, atherosclerosis and asthma. 2 S1P is produced intracellularly by two sphingosine kinases (SphK1 and SphK2) and is the ligand for a family of five G protein-coupled receptors, termed S1P 1-5 . However, there are some actions of S1P that appear to be independent of the known S1PRs. This review will focus on the emerging evidence for S1P as a second messenger.
Sphingolipid Metabolism
Sphingolipids are ubiquitous components of the lipid bilayer of eukaryotic cells. Like glycerolipids, numerous agonists regulate sphingolipid metabolism to generate signaling molecules, including ceramide (N-acyl sphingosine), sphingosine and sphingosine-1-phosphate (S1P). 1, 3, 4 Ceramide, the backbone of all sphingolipids, is produced both by de novo synthesis and by turnover of sphingolipids, such as hydrolysis of sphingomyelin by sphingomyelinases. It is important to note that sphingosine is not produced de novo and is only formed by catabolism of sphingolipids. The 3-ketosphinganine formed is rapidly reduced to dihydrosphingosine, which is subsequently N-acylated by one of a family of six (dihydro)ceramide synthases (CerS, formerly referred to as LASS) to form dihydroceramide, with the CerSs having differing but overlapping preferences for acyl chains from 16 to 26 carbons long. Finally, a 4-5 trans double bond is introduced in the sphingoid base to produce ceramide. Ceramide is then trafficked from the ER to the Golgi, where a variety of head groups are added, forming sphingolipids. After removal of these head groups during catabolism, deacylation of ceramide by ceramidases yields sphingosine, the most common sphingoid base in mammals. It is important to note that sphingosine and dihydrosphingosine (sphinganine) are not produced de novo and are only formed by catabolism of sphingolipids. These sphingoid bases can be re-utilized for complex sphingolipid biosynthesis or phosphorylated by two sphingosine kinases (SphK1 and SphK2) to form S1P. S1P can be degraded either by reversible dephosphorylation to sphingosine by phosphatases, including lysosomal phosphatases, members of the LPP family of lipid-specific phosphatases and two S1P-specific phosphatases, termed SPP1 and SPP2 (reviewed in 5), or degraded by irreversible cleavage to ethanolamine phosphate and hexadecenal by S1P lyase (SPL). 6 Ceramide and sphingosine, the precursors of S1P, are important regulatory components of stress responses, typically inducing growth arrest and apoptosis. 3, 4 In contrast, S1P has been implicated in motility and cytoskeletal rearrangements, formation of adherens junctions, proliferation, survival, angiogenesis and the trafficking of immune cells. 1,7-9 Thus, the dynamic balance between S1P and ceramide and the consequent regulation of opposing signaling pathways, is an important factor that determines cell fate. 10 S1P produces many of its effects by acting as a ligand for one or more of its five receptors, discussed below. However, although intracellular targets for both ceramide and sphingosine have been identified, indicating they are both bona fide second messengers, intracellular targets for S1P have remained elusive.
Sphingosine Kinases
Oddly, like mammalian SphKs, two SphK isoenzymes are also found in organisms as diverse as yeast, slime molds, worms, flies and mammals. 7 In mammals, both SphKs have a broad and overlapping tissue distribution, with SphK1 predominating in lung and spleen and SphK2 predominating in the heart, brain and liver. 11, 12 Both SphKs are members of the diacylglycerol kinase family, containing five conserved domains responsible for substrate binding and catalytic activity. 13 Differential activation of SphKs can be determined by in vitro assays, as detergents stimulate SphK1 and inhibit SphK2. 12 Conversely, SphK2 is stimulated by high salt, whereas SphK1 is inhibited. SphK1 and SphK2 have similar endogenous substrate specificities, with both being able to phosphorylate d-erythro-dihydrosphingosine and d-erythro-sphingosine, the two mammalian sphingoid bases. 11,13 Cells contain both S1P and dihydro-S1P and both activate cell surface S1PRs with essentially the same affinity (see below). S1P predominates both in cells and plasma and thus for the purposes of this review "S1P" will refer to all phosphorylated sphingoid bases, including phyto-S1P found in yeast and plants, unless otherwise indicated. SphK1 and SphK2 are primarily cytosolic, although their distributions are altered in different cell types and by various signals (see below). Homozygous single knockouts of either isoenzyme are viable and there are also no obvious phenotypes in yeast 14 or mice, 15, 16 suggesting that they may have redundant, overlapping, or compensatory functions. Intriguingly, there is no functional redundancy in Drosophila, as deletion of Sk2 but not Sk1 results in flight defects and reduced fecundity. 17 In yeast, even the double knockouts are viable. 14 However, when Sphk1 << and Sphk2 << mice were crossed, mice lacking 1 to
